These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32149837)

  • 1. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
    Kooper-Johnson S; Mahalingam M; Loo DS
    Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic melanoma with sarcomatoid dedifferentiation.
    Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
    Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B; Su A; Binder S; Dry S
    Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of nodal metastases in melanoma using sox-10.
    Jennings C; Kim J
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
    Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
    Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary intrafascial desmoplastic melanoma with pseudoglandular differentiation and aberrant cytokeratins expression: An exceptional presentation.
    Saggini A; Cerroni L; Casini B; Baciorri F; Cota C
    Pathol Res Pract; 2019 Dec; 215(12):152668. PubMed ID: 31585813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review.
    Bastos Junior Cde S; Piñeiro-Maceira JM; Moraes FM
    An Bras Dermatol; 2013; 88(3):408-12. PubMed ID: 23793214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall.
    Valero-Torres A; Prieto VG; Nagarajan P; Torres-Cabala CA; Tetzlaff MT; Curry JL; Ivan D; Aung PP
    Am J Dermatopathol; 2017 Jun; 39(6):468-470. PubMed ID: 28525424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Palisading in Melanoma Mimicking Basal Cell Carcinoma: A Case Report.
    Wang Y; Guo Y
    Am J Dermatopathol; 2020 Sep; 42(9):677-679. PubMed ID: 32195676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous desmoplastic melanoma.
    Busam KJ
    Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
    Romano RC; Carter JM; Folpe AL
    Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
    Tran TAN; Linos K; de Abreu FB; Carlson JA
    Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.